Provided by Tiger Fintech (Singapore) Pte. Ltd.

BELLUS Health Inc.

14.74
0.0000
Volume:- -
Turnover:- -
Market Cap:1.87B
PE:-20.45
High:14.74
Open:14.74
Low:14.74
Close:14.74
Loading ...

Company Profile

Company Name:
BELLUS Health Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada.